Effectiveness of using long-acting angiotensin II type 1 receptor blocker in Japanese obese patients with metabolic syndrome on morning hypertension monitoring by using telemedicine system (FUJIYAMA Study)

References

• Formica M, Quarello F, Stramignoni E, et al. Informatics support and teledialysis [Italian]. Minerva Urol Nefrol 1994;46:11–16
   PubMedGoogle Scholar
• Nakamoto H, Kawamoto A, Tanabe Y, et al. Telemedicine system for CAPD patients by using cellular phone. Adv Perit Dial 2006;19:124–9
   Google Scholar
• Nakamoto H, Hatta M, Tanaka A, et al. Telemedicine system for home automated peritoneal dialysis. Adv Perit Dial 2000;16:191–4
   PubMedGoogle Scholar
• Nakamoto H, Nishida E, Ryuzaki M, et al. Effect of telmisartan and amlodipine on home blood pressure by monitoring newly developed telemedicine system – monitoring test by using telemedicine; Telmisartan’s effect on home blood pressure (TelTelbosu). Clin Exp Hypertens 2008;30:57–67
   PubMed Web of Science ®Google Scholar
• Nakamoto H. Telemedicine system in patients on CAPD. Perit Dial Int 2007;27:S21–6
   PubMed Web of Science ®Google Scholar
• Ryuzaki M, Nakamoto H, Nishida E, et al. Crossover study of amlodipine versus nifedipine CR with home blood pressure monitoring via cellular phone: Internet-mediated open-label crossover trial of calcium channel blockers for hypertension (I-TECHO trial). J Hypertens 2007;25:2352–8
   PubMed Web of Science ®Google Scholar
• Grunday SM, Cleeman JL, Daniels SR, et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735–52
   PubMed Web of Science ®Google Scholar
• The International Diabetes Federation. The IDF consensus worldwide definition of metabolic syndrome; 2005. Available from: www.idf.org
   Google Scholar
• Committee to Evaluate Diagnosis Standards for Metabolic Syndrome Definition and the diagnostic standard for metabolic syndrome. J Jpn Soc Int Med 2005;94:794–809 (in Japanese)
   Google Scholar
• Matsuzaki Y. Metabolic syndrome-definition and diagnosis criteria in Japan. J Atheroscler Thromb 2005;12:301
   PubMed Web of Science ®Google Scholar
• Coleman A, Freeman P, Steel S, Shennan A. Validation of the Omron 705IT (HEM-759-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol. Blood Press Monitor 2006;11:27–32
   PubMed Web of Science ®Google Scholar
• Stergiou GS, Yiannes NG, Rarra VC. Validation of the Omron 705IT oscillometric device for home blood pressure measurement in children and adolescents: The Arsakion School Study. Blood Press Monitor 2006;11:229–34
   PubMed Web of Science ®Google Scholar
• Braun RP, Vecchietti JL, Thomas L, et al. Telemedical wound care using a new generation of mobile telephone: a feasibility study. Arch Dermatol 2005;141:254–8
   PubMed Web of Science ®Google Scholar
• Azizi M, Chedid A, Oudard S. Home blood-pressure monitoring in patients receiving Sunitinib. N Eng J Med 2008;358:95–7
   PubMed Web of Science ®Google Scholar
• McClennan KJ, Markham A. Telmisartan. Drugs 1998;56:1039–44
   PubMed Web of Science ®Google Scholar
• Mallion JM, Siche JP, Laucourciere Y, Telmisaratn Blood Pressure monitoring Group. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension. J Hum Hypertens 1999;13:657–64
   PubMed Web of Science ®Google Scholar
• William BW, Yves L, Giora D. Effects of the angiotensin II receptor blockers relmisartan versus valsartan on the circadian varisation of blood pressure. Am J Hypertens 2004;17:347–53
   PubMedGoogle Scholar
• Littlejohn T, Mrozek W, Marbury T, et al. A prospective, randomized open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension. J Hum Hypertens 2000;16:1123–32
   Google Scholar
• Michel MC, Foster C, Brunner HR, Liu L. A systemic comparison of clinically used angiotensin II type 1 receptor antagonists. Pharmacol Rev 2013;65:809–48
   PubMed Web of Science ®Google Scholar
• Israili ZH. Clinical pharmacokinetics of aniotensin II (AT1) receptor blockers in hypertension. J Hum Hypertens 2000;14: S73–86
   PubMed Web of Science ®Google Scholar
• Ohno K, Amano Y, Kakuta H, et al. Unique “delta Lock” structure of telmisartan is involved in its strongest binding affinity to angiotensin II type 1 receptor. Biochem Biophys Res Commun 2011;404:434–7
   PubMed Web of Science ®Google Scholar
• Kalaitzidis RG, Sarafidis PA, Bakris GL. Effects of thiazolidiones beyond glycemic control. Curr Pharm Des 2009;15:529–36
   PubMed Web of Science ®Google Scholar
• Derosa G, Salvadeo SA. Pioglitazone and rosiglitazone effects of treatment with a thiazolidinedione on lipids and non-conventional cardiovascular risk factors. Curr Clin Pharmacol 2008;3:77–84
   PubMedGoogle Scholar
• Kurtz TW, Pravenec M. Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin–angiotensin system. J Hypertens 2004;22:2253–61
   PubMed Web of Science ®Google Scholar
• Bakris G, Burgess E, Weir M, et al. Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy. Kidney Int 2008;74:364–9
   PubMed Web of Science ®Google Scholar
• Bakris G, Viberti G, Weston WM, et al. Rosiglitazone reduces urinary albumin excretion in type II diabetes. J Hum Hypertens 2003;17:7–12
   PubMed Web of Science ®Google Scholar
• Bahadir O, Uzunlulu M, Oguz A, et al. Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome. Hypertens Res 30:49–53
   Google Scholar
• Imai Y, Poncelet P, DeBuyzere M, et al. Prognostic significance of self-measurements of blood pressure. Blood Press Monit 2000;5:137–43
   PubMed Web of Science ®Google Scholar
• Mengden T, Hernandez M, Edina RM, et al. Reliability of reporting self-measured blood pressure values by hypertensive patients. Am J Hypertens 1998;11:1413–17
   PubMed Web of Science ®Google Scholar
• Johnson KA, Partsch DJ, Rippole LL, McVey DM. Reliability of self-reported blood pressure measurements. Arch Intern Med 1999;159:2689–93
   PubMed Web of Science ®Google Scholar
• Nordmann A, Frach B, Walker T, et al. Reliability of patients measuring blood pressure at home: prospective observational study. BMJ 2000;9:200–5
   Google Scholar
• Pickering TG, Gerin W, Holland JK. Home blood pressure teletransmission for better diagnosis and treatment. Curr Hypertens Reports 1999;1:489–94
   PubMedGoogle Scholar
• Verberk WJ, Kroon AA, Kessels AGH, de Leeuw PW. Home blood pressure measurement. A systemic review. J Am Coll Cardiol 2005;46:743–51
   PubMed Web of Science ®Google Scholar
• Friedmann RH, Kazis LE, Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 1996;9:285–92
   PubMed Web of Science ®Google Scholar
• Rudd P, Miller NH, Kaufmann J, et al. Nurse management for hypertension: a system approach. Am J Hypertens 2004;17:921–7
   PubMed Web of Science ®Google Scholar
• Bondman M, Bolger N, Castro G, Avitall B. The effect of home monitoring and telemanagement on blood pressure control among African Americans. Telemed J 2006;6:15–23
   Google Scholar
• Artinian NT, Washington OGM, Templin TN. Effects of home telemonitoring and community-based monitoring on blood pressure control in urban African Americans: a pilot study. Heart Lung 2001;30:191–9
   PubMed Web of Science ®Google Scholar
• Rogers MAM, Small D, Buchan DA, et al. Home monitoring service improves mean arterial pressure in patients essential hypertension. Ann Intern Med 2001;134:1024–32
   PubMed Web of Science ®Google Scholar
• Madsen LB, Kirkrgaard P, Pedersen EB. Blood pressure control during telemonitoring of home blood pressure. A randomized controlled trial during 6 months. Blood Press 2008;17:78–86
   PubMed Web of Science ®Google Scholar
• Demers J, Kane MP, Bakst G, et al. Accuracy of home blood glucose monitors using forearm blood samples: FreeStyle versus One Touch Ultra. Am J Health Syst Pharm 2003;60:1130–5
   PubMed Web of Science ®Google Scholar
• Holbrook EA, Barreira TV, Kang M. Validity and reliability of Omron Pedometers for prescribed and self-paced walking. Med Sci Sports Exer 2009;41:669–73
   Google Scholar